GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,000 | +100.0% | 10 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 10 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $2,000 | 0.0% | 10 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $2,000 | +100.0% | 10 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -80.0% | 10 | -80.0% | 0.00% | -100.0% |
| Q2 2017 | $5,000 | -16.7% | 50 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $6,000 | 0.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $6,000 | -14.3% | 50 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $7,000 | +40.0% | 50 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $5,000 | +25.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $4,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 134,230 | $9,085,000 | 5.95% |
| VHCP Management, LLC | 311,853 | $21,106,000 | 5.81% |
| Iguana Healthcare Management, LLC | 60,000 | $4,061,000 | 1.96% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 366,187 | $24,784,000 | 0.95% |
| ACUTA CAPITAL PARTNERS, LLC | 20,000 | $1,354,000 | 0.92% |
| United Asset Strategies, Inc. | 14,278 | $966,000 | 0.41% |
| PRUDENTIAL PLC | 823,408 | $55,728,000 | 0.24% |
| Rock Springs Capital Management LP | 28,000 | $1,895,000 | 0.22% |
| CLOUGH CAPITAL PARTNERS L P | 84,600 | $5,726,000 | 0.20% |
| Eventide Asset Management | 25,000 | $1,692,000 | 0.18% |